行情

CPHI

CPHI

中国医药控股
AMEX

实时行情|Nasdaq Last Sale

0.2513
-0.0037
-1.45%
已收盘, 16:00 11/13 EST
开盘
0.2550
昨收
0.2550
最高
0.2586
最低
0.2500
成交量
4.46万
成交额
--
52周最高
0.5800
52周最低
0.1950
市值
1,095.15万
市盈率(TTM)
-1.0232
分时
5日
1月
3月
1年
5年

CPHI 新闻

  • Introducing China Pharma Holdings (NYSEMKT:CPHI), A Stock That Climbed 37% In The Last Three Years
  • Simply Wall St..10/28 12:39
  • Our Take On China Pharma Holdings, Inc.'s (NYSEMKT:CPHI) CEO Salary
  • Simply Wall St..09/13 12:17
  • China Pharma Holdings, Inc. Has Entered into A Memorandum of Understanding With World Health Advanced Technologies, Ltd.
  • PR Newswire.09/11 13:00
  • Edited Transcript of CPHI earnings conference call or presentation 15-Aug-19 12:30pm GMT
  • Thomson Reuters StreetEvents.09/05 21:07

更多

所属板块

生物技术和医学研究
+0.42%
制药与医学研究
+0.16%

热门股票

名称
价格
涨跌幅

CPHI 简况

China Pharma Holdings, Inc. is a holding company. The Company conducts its production, marketing, finance, development and administrative activities through its subsidiary, Hainan Helpson Medical & Biotechnology Co., Ltd. (Helpson) in the People's Republic of China (PRC). It is engaged in the development, manufacture and marketing of pharmaceutical products for human use in connection with various diseases and medical conditions in the PRC. It manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, oral solutions and granules. Its pharmaceutical products are sold on a prescription basis and are approved by the China Food and Drug Administration (the CFDA). The Company manufactured over 20 pharmaceutical products for various diseases and medical indications. It offers products for Central Nervous System (CNS) and Cerebral-Cardiovascular Diseases, Anti-infection and Respiratory Diseases, Digestive Diseases and Others.
展开

Webull提供China Pharma Holdings, Inc.的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。